The adverse events of chemotherapy for retinoblastoma: What are they? Do we know? Journal Article

  

Authors:	Rizzuti, A. E.; Dunkel, I. J.; Abramson, D. H.
Article Title:	The adverse events of chemotherapy for retinoblastoma: What are they? Do we know?
Keywords:	cancer chemotherapy; cancer survival; constipation; drug tolerability; neutropenia; diarrhea; monotherapy; side effect; antineoplastic agents; carboplatin; infection; liver toxicity; multiple cycle treatment; nephrotoxicity; neutrophil count; bone marrow suppression; etoposide; nausea; thrombocytopenia; vomiting; antineoplastic combined chemotherapy protocols; editorial; cyclophosphamide; vincristine; hemoglobin blood level; retinoblastoma; retinal neoplasms; abdominal pain; febrile neutropenia; fever; gastrointestinal toxicity; disease severity; thrombocyte count; sepsis; external beam radiotherapy; leukocyte count; adverse drug reaction; cyclosporin; ototoxicity
Journal Title:	Archives of Ophthalmology
Volume:	126
Issue:	6
ISSN:	0003-9950
Publisher:	American Medical Association
Date Published:	2008-06-01
Start Page:	862
End Page:	865
Language:	English
DOI:	10.1001/archopht.126.6.862
PUBMED:	18541855
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-45149116184&partnerID=40&md5=d13ae185fa12c0871ae8954d1cba689d
Notes:	--- - "Cited By (since 1996): 6" - "Export Date: 17 November 2011" - "CODEN: AROPA" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/15220